Congressional Investigation of Pharmacy Rebates on Medicaid Drugs
Client Alert | less than 1 min read | 01.16.04
The House Energy and Commerce Committee and its Subcommittee on Oversight and Investigations have asked five large retail pharmacy chains for documents on pharmaceutical reimbursements and rebates under Medicaid. The committee is concerned that drug manufacturers may have been engaged in improper "marketing of the spread," to the detriment of state Medicaid programs. The letters expressed concern that drug manufacturers could be charging low prices on particular prescription medications to their customers, while submitting inaccurate or incomplete cost or price information that becomes the basis of state Medicaid reimbursement for the drug at much higher prices. The January 14th letters were sent to CVS, Eckerd, Rite Aid, Walgreen, and Wal-Mart.
Contacts
Insights
Client Alert | 2 min read | 03.11.26
On March 3, 2026, a bipartisan coalition of state attorneys general and state charity regulators (the “States”) sent a letter[1]to GoFundMe expressing their concerns about GoFundMe's creation of donation web pages for more than 1.4 million charities without their prior knowledge or consent.
Client Alert | 3 min read | 03.11.26
Civil Litigation as a First-Response Strategy: The UK Government's Fraud Strategy 2026–2029
Client Alert | 5 min read | 03.11.26
CJEU Sets the Bar Low for Evidence Disclosure in Competition Damages Litigation
Client Alert | 6 min read | 03.11.26
